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Differential Expression of Chemokines
in a Mouse Model ofWound Healing
Susan H. Jackman, I Matthew B. Yoak, 2 Shivaleela Keerthy, I Bonnie L. Beaver2
Marshall University School of Medicine, Huntington, West Virginia
1 Department of Microbiology, Immunology, & Molecular Genetics; 2 Department of Surgery

Abstract. Macrophages have a multifaceted role in wound healing. While their initial activity may be in the
degradation and elimination of damaged tissue, macrophages also produce and secrete a variety of mediators
that can participate in the repair process as well. To perform these functions, macrophages must be recruited to
a wound site. Our purpose was to examine the temporal and spatial expression of macrophage chemoattracting
cytokines (chemokines) at a surgical wound site. A surgical wound was prepared on the dorsal aspect ofB6AFI/J
mice.. Biopsies were obtained from the wound and a comparable nonwounded area between 6 and 72 hr after
wounding. The presence or absence of various chemokine mRNAs was detected by the reverse transcriptasepolymerase chain reaction (RT-PCR). Immunohistochemical staining and in situ RT-PCR determined localization
of cells producing chemokines. In wounded tissue, both macrophage chemoattractant protein- I (M CP-1) and
macrophage inflammatory protein-1 (MIP-1) were detected; however, the time of expression differed for each
molecule. MCP-1 mRNA was detected at 6 hr after wounding, with decreased expression at subsequent time
periods. In contrast, MIP-1 messages were not observed until 24 hr after wounding, and steadily increased
thereafter. MCP-1 and MIP-1 mRNA and protein were localized predominantly in keratinocytes. The rapid
and strong expression of MCP-1 and MIP -1 messages within the wound site suggests a pivotal role for these
chemokines in the repair process. The differences in appearance and level of expression over time, however,
suggest distinctive functions for each chemokine and indicate that the local milieu, rather than a single cytokine,
influences macrophage recruitment and/or activation.
Keywords: Chemokines, wound healing, chemoattractant, MIP-1, MCP-1, TGF-~
Introduction
Healing of wounds requires a network of repair
mechanisms that influence the recruitment and
infiltration of leukocytes at the wound site. During
the inflammatory phase of the repair process,
macrophages are found in increasing numbers and
have been shown to be necessary for wound repair
[1,2]. Yet certain growth factors and cytokines that
are produced and secreted by activated macrophages
have also been implicated in the scarring that occurs
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during wound healing [3]. Understanding the early
mechanisms by which macro phages are recruited to a
wound site could assist in managing the potential
adverse effects of macrophage activation, without
inhibiting the positive functions that macrophages
perform in wound repair.
The ability to attract monocytes from blood into
tissue, where monocytes then differentiate into
activated macro phages, is proposed to be one function
of the chemoattracting cytokines, called chemokines.
The various chemokines appear to be both pleotrophic
and redundant with respect to their target cells and
biological activities, at least when studied in vitro [4].
Local expression of cytokines is required for the
migration of monocytes to extravascular sites [5-7].
While macrophage chemoattractant protein-1 {MCP-1)
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[5,6] and macrophage inflammatory protein-1 (MIP-1)
[6-9] have both been observed within wounds,
correlation of their appearance has not been explored.
To investigate the roles of these monocyte-attracting
chemokines in wound healing, we have used a murine
model of wounding to establish their temporal and
site-specific expression early in the repair process.
Methods and Materials

Animals. Female B6AF1/J mice were purchased from
The Jackson Laboratory (Bar Harbor, ME), housed in
a conventional animal facility, and given food and water
ad libitum. Animals were used at 9-16 weeks of age.
All experiments were approved by the Institutional
Animal Care and Use Committee of Marshall
University School of Medicine.

Experimental design. Mice were anesthetized, the hair
on the dorsal aspect was shaved, and the skin was
prepared for surgery by swabbing with iodine solution.
A single 25-30 mm full-thickness incision was made
and the wound was closed with stainless steel staples.
On some animals, a second site on the dorsal aspect
was designated as nonwounded; here the hair was
shaved and iodine was applied but no wound was made.
This site was at least 8 mm from the wounded site. At
6, 24, 48, and 72 hr after wounding, the wound and
nonwounded sites were excised. Control untreated
skin, that is, skin from animals not shaved nor swabbed
with iodine solution, was also used. Each excised site
was divided into three pieces. One piece was place in
10% buffered formalin, embedded in paraffin,
sectioned, and stained with hematoxylin and eosin. A
second piece was cut into small segments and snapfrozen in liquid nitrogen for RNA extraction. The
third piece was frozen in liquid nitrogen for in situ
RT-PCR and immunohistochemistry.
.

RNA extraction and RT-PCR.

Tissues were
homogenized with a Tekmar SDTTissumizer (Tekmar,
Cincinnati, OH) and total cellular RNA was extracted
using TRizol Reagent (Life Technologies, Grand Island,
NY), according to the manufacturer's instructions. The
extracted RNA was stored at -70°C. RNA in RNasefree water was first incubated for 3 min at 70°C and

chilled on ice. eDNA was synthesized from 1 J..Lg total
RNA in a 30 J..Ll reaction volume using Moloney murine
leukemia virus reverse transcriptase (Gibco-BRL,
Gaithersburg, MD) and oligo d(T) l6· Four J.ll aliquots
of the eDNA reaction products were amplified by PCR
in 50 J.!l reactions using Taq polymerase (PE Applied
Biosystems, Foster City, CA) and 0.4 J.!M each of the
respective primers. The reaction consisted of23 (MCP1) or 35 (all other reactions) cycles in a Perkin-Elmer
DNA Thermal Cycler Model480, with denaturation
at 95°C for 1 min, annealing at 60°C for 1 min, and
extension at 72°C for 2 min. After the final cycle, the
temperature was maintained for an additional 7 min
at 72°C. PCR products were analyzed by electrophoresis on 3% NuSieve/1% SeaKem agarose gels
(FMC Bioproducts, Rockland, ME) and visualized by
ethidium bromide staining. Starting quantities of 1-6
10
x 10- J..Lg of chemokine/cytokine specific cDNAs
produced detectable PCR products. Photographs of
the gels were taken with Polaroid 667 film. The prints
were scanned using Adobe Photoshop software and
inverted images were printed onto Hewlett Packard
transparency film (Palo Alto, CA). Band intensities
were quantified by densitometry using a Personal
Densitometer (Molecular Dynamics Inc, Sunnyvale,
CA) with an OD 260 limit of sensitivity of 0.01 units.
After subtracting background OD 26o• the relative level
for each chemokine or cytokine was calculated as
OD 26o for the chemokine or cytokine band, divided
by the OD 2 6o for the ~-actin band. ~-actin (540 base
pair product), MIP-1 (279 base pair product), and
TGF-~ (525 base pair product) primers were purchased
from Clontech (Palo Alto, CA). The MCP-1 and
oligo d(Th6 primers were synthesized at the Marshall
University DNA Core Facility. The MCP-1 primer
sequences were as follows:
5'primer 5'AGCACCAGCCAACTCTCACT3' and
3'primer 5'TCTGGACCCATTCCTTCTTG3' (301
base pair product).

In situ (IS) RT-PCR. IS RT-PCR was performed using
IS PCR glass slides and the GeneAmp in situ PCR
system 1000 (PE Applied Biosystems). Ten-J..Lm frozen
sections were placed on slides and fixed with 4%
paraformaldehyde in Dulbecco's phosphate buffered
saline (D PBS) for 15 min on ice. In some experiments,
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sections were permeabilized with 0.1 o/o saponin in
DPBS for 5 min on ice. After washing, DNA was
digested with 2U/~l DNase (Worthington
Biochemicals, Freehold, NJ) solution containing 0.1
M sodium acetate and 0.005 M MgSO for 4 hr at
37°C and again in fresh DNase overniiht at 37°C.
After washing, eDNA was synthesized at 42°C for 60
min. On each slide, one section was incubated in a
eDNA reaction mixture without reverse transcriptase
and served as a negative control. PCR was performed
using a 50 ~1 reaction mixture containing 1x IS PCR
reaction buffer, 4.5 mM MgC1 , 0.2 mM each
2
deoxynucleoside triphosphates, 50 ~1 IS Taq
polymerase (PE Applied Biosystems), 10 ~M
digoxigenin-11-dUTP (Boehringer Mannheim,
Indianapolis, IN), and 0.8 ~M each of the respective
primers (M CP -1 and MIP -1). Amplification consisted
of 2 min at 95°C, then 30 cycles of denaturation at
95°C for 1 min and annealing at 60°C for 1 min with
a final extension at 72°C for 7 min. After washing,
incorporation of digoxigenin-11-dUTP was
demonstrated by incubation in alkaline phosphatase
conjugated anti-digoxigenin (Boehringer Mannheim)
overnight at 4 °C, followed by visualization using Vector
Red substrate (Vector Laboratories, Burlingame, CA).
Sections were counterstained with hematoxylin. Five
samples representing three different time periods were
analyzed for each chemokine.

Immunohistochemistry. Skin tissue was snap-frozen
in liquid nitrogen and stored at -70°C. Cryosections
(1 0 !lm) were fixed in acetone for 5 min at room
temperature and then stored at -20°C until used. All
staining was performed at room temperature in a
humidified chamber. On the day of staining, sections
were incubated in 1Oo/o normal goat or hamster serum,
followed by avidin-biotin blocking solution (Vector,
Burlingame, CA). After washing, they were reacted
with primary antibody directed to MCP-1 (hamster
anti-mouse MCP-1, Pharmingen, San Diego, CA) or
MIP-1 (goat anti-mouse MIP-1a, Sigma, St. Louis,
MO), then with biotin-conjugated anti-species IgG.
An avidin: biotinylated horseradish peroxidase complex
(Vectastain ABC Reagent, Vector) was used with
3,3'-diaminobenzidine and hematoxylin counterstain
to visualize cells. Tissue sections treated with PBS
instead of the primary antibody served as control

samples and gave negative results. Two samples
representing two different time periods were analyzed
for each chemokine.

Statistical analysis. Wounded and nonwounded skin
were compared to control (normal) skin for chemokine
and cytokine expression. Some groups were not
normally distributed and nonparametric methods were
therefore used. Groups were compared using the
Kruskal-Wallis one-way ANOVA test (SigmaStat 2.0
program). Significance was defined asp < 0.05.
Results

Detection of chemokine mRNA. We recently
demonstrated the expression of monocyte-attracting
chemokine mRNAs during experimental mouse
wound healing, using RT-PCR [1 0]. Because induction
of chemokines appears exquisitely sensitive to variations
in the tissue environment, we wished, in addition, to
determine the expression of certain chemokines in
normal control skin. In this study, we have confirmed
our findings for the chemokines, MCP-1 and MIP-1,
and the cytokine, TGF-B, and we have compared their
expression in wounded and nonwounded skin with
control (normal) skin, that is, skin neither wounded
nor prepared for surgery. Table 1 shows data for gene
expression of MCP-1, MIP-1 and TGF-B at specific
time periods after wounding. Chemokine or cytokine
values are standardized to B-actin for each specimen
(eg, MCP-1/B-actin ratio) and the data are reported
as relative levels.
MCP-1 mRNA, while undetectable in control
skin, was observed in some animals as early as 6 hr
after wounding. By 24 hr, MCP-1 message was found
in all animals and the levels were significantly higher
in wounded versus control skin at this time and at 48
hr after wounding (p <0.05). Whereas MCP-1
expression was also observed in nonwounded skin, the
levels were not significantly different from those found
in control skin at any time point.
In contrast, the expression of MIP-1 mRNA,
which is constitutively expressed in control (normal)
skin, was dramatically reduced at 6 hr and appeared to
be the result of preparing the skin for surgery, in that
nonwounded and wounded skin both showed this
effect. At 24 hr, MIP -1 message was observed in
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Table I. Relative levels of chemokines and cytokines in control, nonwounded, and wounded skin samplesa

N

MCP-1
mean±SD
[median]

N

3

o.ooh

3

0.30±0.52
[0.00]

3

0.08±0.05
[0.09]

5

0.08±0.12
[0.04]

4

Skin sample
&

time
Control

[0.00]
Nonwounded
6 hr

24 hr

48 hr

3

5

4

MIP-1
mean±SD
[median]

TGF-~

N

mean±SD
(median]

0.37±0.16
(0.441

3

1.61±0.10
[1.56]

o.ooc

4

0.98±1.67
[0.23}

5

0.61±0.14C
[0.61]

4

0.76±0.47C
[0.58]

[0.00]

o.ooc
[0.00]

o.ooc
[0.00]

72 hr

4

0.08+0.14
(0.01]

4

0.40±0.43
[0.37]

4

0.81±0.32C
[0.94]

Wounded
6 hr

5

0.59±0.56
[0.82]

5

o.ooc

5

0.72±0.35
[0.53]

24 hr

6 0.38±0.28C
(0.36]

6

O.l6±0.13C
[0.14]

6

0.64±0.32C
[0.531

48 hr

5 0.30±0.}9C
[0.21]

5

0.37±0.22
[0.28]

5

0.55±0.23C
[0.57]

72hr

6

6

0.67±0.31
[0.68]

6

0.88±0.39C
[0.93]

0.49±0.50
[0.40]

[0.00]

aN"' number of specimens analyzed. b Chemokine/cytokine levels below the detection limits are given a value of 0.00.
c p <0.05 vs control skin samples, computed by Kruskal-Wallis one-way ANOVA..

wounded skin, albeit at low levels, and it recovered to
control skin levels by 48 hr. In comparison, MIP-1
was not detected in nonwounded skin until 72 hr, at
which time it had returned to control skin levels.
TGF-~ transcripts were also examined and
comparable levels were found in both wounded and
nonwounded skin, but were significantly decreased
relative to control skin (p<0.05), with the exception
of samples obtained at 6 hr after wounding.

In situ localization of MCP-1 and MIP-1. In situ
RT-PCR was used to study the distribution ofMCP-1
and MIP-1 mRNA in wounded skin (Fig. lA, IB).
Sections were first treated with DNase to remove

genomic DNA and then reverse transcribed to generate
eDNA for all mRNAs. This was followed by amplification with specific primers. For both MCP-1 and
MIP-1, intensely positive single cells were found in a
scattered pattern in the epidermis. Other cells positive
for both chemokines were detected mainly in the lower
dermis. MIP-1 mRNA was also consistently observed
in follicular epithelium and sebaceous gland cells, while
MCP-1 mRNA was only occasionally found in this
location. Specificity of the messages was confirmed
by lack of signal in sections incubated without reverse
transcriptase (Fig. 1C).
The presence ofMCP-1 and MIP-1a protein in
wounded skin was detected by immunohistochemical

Hr,. I. J.ocali:-.uion of MCl'·l '"'d MIP-1 m.KNA by in situ RT-l'CR. Ti.<>ue sections from wnunded skin, treated with
DNwe to ocmovc genomic D!\JA. -were rt:vc::uc rwuc1·Ched ~tlC.i ch~n amprilkd ''-'i• f1 S!lt:dtl,: l'timt:n and labclc<l m.1deotidc:.
PCR produ<" were detectod ~'Y ;uttibody tn d,. nud•otidc label. At 72 lor anrr wounding, MCP-1 (;\) and ~lP-1 (lj)
message:; we~ (c)und \\-ichin dte epi(ferm(s, hair fuHk1t:s, ;,md sdt::tccous gland~. and in ,:~U~ ln t'1e li'>Wt:"I <l~rtuls. {C} A
n~tl,•econttol section. treated :AS dcs.ct·ibed hut nor reverse tr3JlSCti6ed pri<tr rn PCR.arnpliflc.aliou, d~rnonstmocs:. ncg~ti,,c
!\:action; secdun :;hown is fcn .\4( ;p_ 1, with similar rcsufL,. for Mlfl-1. 1 hG pl:orograph d~picLS ri,..~uc: .lJ)J)I'l.t:<im.u.d}· I mm
from che indskm sit~. (Vcccor Red ch1't)fllogr.n with hanatOX}'Iin: origiu:ll ntolgn.itk~rir.m xl50).

-lt•ining. ~Cl'-1 immuttoteactivity '"·' found
predominantly wit.hin the <piderntis (rig. 2.'\) corresponding to MCP-1 mR~A expression. Likewise .
.\111'-let protein p.r~lleled its m RKA \octli:L.1rion. wich
positive sto.itting itt the epidermis attd follkular
L1'itholium and in assuciatiou with ,,t:haccmL' gland.s
(fig. 2B). We•lc hur spcdlic: Mll'-lo: re-activity wa.<

~!so ob.etved

it> dcrtual t:dls (Pit:- 2R). No .raining
for either prutein could. bo <letoc:tc-d in control seCtions
in which tlu: primary antib<>dyw•s not used (rit:· 2C).
For both tech niquc~, rhe srai n5ng patccrn.~ were
independently "'sessed by rwo ofche author:; •nd were
cnnfirmed by a c·f\ird person with ~xpcnise in
microanarom}:

Fig. 2. Localizadon ofMCP -1 and ~·HP-1 a prutdn by .ln)muru)hiM ln::ht:nli~u-;... Ti:,sllc sc.:t.iuns l'mm sl<in Gh1· afoc1· wounding
io·· MCI'-1 (A) or 72 hr >ft·•· WOllllding r()r Mli'·lll (U) reveal spt-cific signal within the epidcnnis :md '" edb iro '"' drrorus.
\1flJ.-ja is :tlso found in h~lrf(lllicl~ :~nd schact:nm ~bnd.s (B). (C) S~cLi.<)th h1 whi.dl Lhc:: ]Jrlnlacy 3U{ibodywas llOL uSt-d
dcmoh:,t1·a1e ~l ncgatr:c rcac(ion; soc.tion ~hown fur 1\:ICI'-l with l:omp:trablr: ~..~uln fl1r ~..iJI)-1tl. '11u: phntt'J~r.aph clc:piciS
tismc approxjm.1tc::ty 1 tn11l fr<un tht: irH.:isl<nl siLc. (DAB duomogt:n with hcmaro.~:in; origin:1~ magnlficacion x 400).
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Discussion
Elucidating the mechanism for recruitment and
activation of macrophages at a wound site is essential
for a complete understanding of this cell's role in the
repair process. In the present study, we employed a
surgically wounded mouse model to examine the
pattern and localization of monocyte-attracting
chemokine gene expression in vivo.
Prior studies in mice and humans show that M CPI [5-7] and MIP-I [6-9] are both associated with
wounding. Whereas in previous investigations, each
chemokine was studied either individually or at only
one time period, in this study we tested both M CP -I
and MIP-I at several times after wounding. MCP-I
appeared before MIP-I, with expression at 6 hr after
wounding [5], while MIP-I did not appear until 24
hr, with increasing expression through 72 hr [8,9].
These present results confirmed previous findings.
Our experimental design, however, revealed several
unexpected observations in regard to MCP-I
expression. First, by making a distinction between
nonwounded versus control (normal) skin, we found
MCP-I, albeit at very low levels, in nonwounded but
not control skin. While this difference may reflect the
biopsy of nonwounded skin too dose to the wound,
careful efforts were made to delineate the two samples.
Alternatively, our observation suggests that induction
ofMCP-I gene expression at cutaneous sites is highly
sensitive to mechanical or chemical stress and that the
clipping of hair and/or treatment of the site with iodine
in preparation for surgery may have initiated the slight
expression of MCP-I detected in nonwounded skin.
Indeed, induction of cytokine expression is reported
in mild epidermal barrier disruption in humans [II],
lending support to this hypothesis. In addition, the
appearance ofMCP-1, even within wounded skin, was
at relatively low levels, an observation that is consistent
with reports that tissue-specific low levels result in
accumulation of monocytes, while high levels of
expression do not [I2]. This suggests that inducing
the optimal amount of MCP-1, rather than eliciting
expression per se, may be necessary for the recruitment
of monocytes/macrophages to a wound.
For MIP-I mRNA, we observed constitutive
expression in normal skin, supporting most [I5-I7]
but not all [9] investigations. Based on these levels in

control skin, the striking lack of MIP-1 at 6 hr post
wounding, with a gradual increase to normal skin levels,
implies an alternative function for this chemokine.
Rather than recruiting macrophages to a wound site,
MIP-1 may instead fine-tune the macrophages'
activities [ 19] and promote other wound repair
processes [9]. The increase in MIP-1 message after
the appearance ofMCP-I in our model suggested that
MIP-1 was modulating the inflammatory response
rather than initiating it.
Cytokines are seldom expressed in isolation from
other cytokines, so functionality must be assessed in
conjunction with other molecules in the local milieu.
TGF-I3, a pleotrophic molecule involved in promoting
the repair process [13], has also been shown to have an
inhibitory effect on MCP-1 expression in macrophages
[I4]. Decrease in TGF-13 in our model, concomitant
with increased MCP-1 expression, suggests that
physiologic concentrations in concert with timed
expression may determine the function of a cytokine
at a local site.
In our study, we also investigated the site of
chemokine production by in situ RT-PCR and
immunohistochemistry. Other reports localized
MCP-1 to monocytes/macrophages [5-7,20] and to
cells within the epidermis [7,20] and dermis [5,20].
Likewise, MIP-1 has also been identified in
macrophages [6,9] as well as within the epidermis
[16,17]. While we clearly found both MCP-1 and
MIP-1 message and protein within the epidermis and
at lower dermal locations, we also consistently observed
both chemokines associated with hair follicles and
sebaceous glands. It is interesting that the strongest
expression was in cells of epithelial lineage. The
implication of this finding with respect to function
warrants further study.
Although the exact role of chemokines in the
sequence of events and cellular interactions in the
inflammatory phase of wound healing is still under
investigation, it has been established that they are key
molecules in the development of the repair process.
By examining the differential expression of several
chemokines/ cytokines, our study suggested that to
determine adequately the function of any particular
cytokine in wound healing, its expression must be
examined, not only with respect to time and place,
but also in the context of the local milieu of other
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cytokines. Such information may provide new
strategies for enhancing repair processes by
manipulating, directly or indirectly, macrophage
activities at a wound site.
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